Bristol-Myers Squibb Stock
Bristol-Myers Squibb Stock
Bristol-Myers Squibb gained 2.070% today.
Our community is currently high on Bristol-Myers Squibb with 11 Buy predictions and 3 Sell predictions.
With a target price of 67 € there is a hugely positive potential of 76.78% for Bristol-Myers Squibb compared to the current price of 37.9 €.
Our community identified positive and negative aspects for Bristol-Myers Squibb stock for the coming years. 4 users see the criterium "Worthwhile Investment for the next years" as a plus for the Bristol-Myers Squibb stock. On the other hand our users think that "Business model" could be a problem in the future.
Pros and Cons of Bristol-Myers Squibb in the next few years
Pros
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
S********** s********
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Bristol-Myers Squibb vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Bristol-Myers Squibb | 2.070% | -0.303% | -7.931% | -37.252% | -18.319% | -29.501% | -6.696% |
Pfizer Inc. | 1.400% | -0.751% | 9.877% | -25.891% | 1.226% | -17.127% | -25.294% |
Elanco Animal Health Inc. | 0.760% | 4.935% | 31.803% | 113.202% | 20.163% | -44.723% | - |
Biogen Inc. | 2.070% | 3.184% | 2.979% | -25.234% | -12.044% | -5.210% | 5.333% |
Comments
Bristol-Myers Squibb (NYSE: BMY) had its price target lowered by analysts at Bank of America Co. from $72.00 to $68.00. They now have a "buy" rating on the stock.
Show more
Ratings data for BMY provided by MarketBeat
Bristol-Myers Squibb (NYSE: BMY) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $81.00 to $69.00. They now have a "buy" rating on the stock.
Show more
Ratings data for BMY provided by MarketBeat
Bristol-Myers Squibb (NYSE: BMY) had its price target lowered by analysts at Morgan Stanley from $56.00 to $50.00. They now have an "underweight" rating on the stock.
Show more
Ratings data for BMY provided by MarketBeat